Insmed Incorporated (INSM)
$72.75
Insmed Incorporated (INSM) Share Price Forecast
Currently 23 wall-street analysts regularly analyze the financials of Insmed Incorporated on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Insmed Incorporated (INSM) have a share price target of $88.69. This median of share price forecast represents a 21.91% upside from the latest price of $72.75 as on 21.10.24.
Insmed Incorporated (INSM) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Insmed Incorporated (INSM) share price will touch around $88.69 in next 12-months.
Insmed Incorporated (INSM) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Insmed Incorporated's share price and its median forecast price. As on 21.10.24, the difference is -17.83%
Insmed Incorporated (INSM): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Insmed Incorporated (INSM) Share Price : Analyst Recommendation
Based on 23 analysts tracking and researching Insmed Incorporated (INSM) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 13 | 14 | 15 |
| Outperform | 6 | 7 | 7 |
| Hold | 1 | 1 | 1 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Insmed Incorporated (INSM) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Insmed Incorporated (INSM) is $88.69, offered by 23 analysts offering 12-month price forecasts.
Insmed Incorporated (INSM) has a maximum of 0.22 upside potential, based on 23 analysts offering 12-month price forecasts.
Based on 23 analysts tracking and researching Insmed Incorporated (INSM), 95.65% have a buy recommendation. Remaining 4.35% have either sell or hold recommendations.
The latest share price of Insmed Incorporated (INSM) is $72.75 as of 21/10/2024.
22 of total 23 analysts offering stock ratings for Insmed Incorporated INSM have recommended buy rating.
₹0 US Stocks a/c Opening Fee